The essentiality of arachidonic acid in infant development

Nutrients

Volumn 8, Issue 4, 2016, Pages

  Hadley, Kevin B ^a   Ryan, Alan S ^b   Forsyth, Stewart ^c   Gautier, Sheila ^a   Salem, Norman ^a  

^a DSM NUTRITIONAL PRODUCTS   (United States)

^b Clinical Research Consulting   (United States)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Arachidonic acid; Docosahexaenoic acid; Growth; Human milk; Infant formula; Long chain polyunsaturated fatty acids

Indexed keywords

12 HYDROXYICOSATETRAENOIC ACID; ACYL COENZYME A DESATURASE 1; ARACHIDONIC ACID; CORTICOTROPIN RELEASING FACTOR; DOCOSAHEXAENOIC ACID; GAMMA INTERFERON; ICOSANOID; INTERLEUKIN 1; INTERLEUKIN 13; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; LINOLEIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHOLIPASE A2; POLYUNSATURATED FATTY ACID; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; SNARE PROTEIN; SYNTAXIN; TUMOR NECROSIS FACTOR ALPHA;

BIOSYNTHESIS; BODY FAT DISTRIBUTION; BONE METABOLISM; BRAIN FUNCTION; BREAST MILK; CELLULAR IMMUNITY; CHILD GROWTH; CHILD HEALTH; FAT INTAKE; FATTY ACID METABOLISM; GENETIC POLYMORPHISM; GROSS NATIONAL PRODUCT; HUMAN; IMMUNOMODULATION; INFLAMMATION; INTRACELLULAR SIGNALING; NERVE FIBER GROWTH; NERVOUS SYSTEM DEVELOPMENT; REVIEW; SURVIVAL; CHEMISTRY; CHILD DEVELOPMENT; INFANT; METABOLISM; NUTRITIONAL REQUIREMENT;

ARACHIDONIC ACID; CHILD DEVELOPMENT; DOCOSAHEXAENOIC ACIDS; HUMANS; INFANT; MILK, HUMAN; NUTRITIONAL REQUIREMENTS;

EID: 84963750203     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu8040216     Document Type: Review

References (303)

1. Martinez, M. Tissue levels of polyunsaturated fatty acids during early human development. J. Pediatr. 1992, 120, S129–S138. [CrossRef]
2. Koletzko, B.; Carlson, S.E.; van Goudoever, J.B. Should infant formula provide both omega-3 DHA and omega-6 arachidonic acid? Ann. Nutr. Metab. 2015, 66, 137–138. [CrossRef] [PubMed]
3. Bolling, K. Infant Feeding Survey, 2005. Available online: http://www.hscic.gov.uk/pubs/ifs2005 (accessed on 17 August 2015).
4. Centers for Disease Control and Prevention, Division ofNutrition, Physical Activity, and Obesity. Breastfeeding Report Card, 2014. Available online: http://www.cdc.gov/breastfeeding/data/reportcard.htm (accessed on 18 August 2015).
5. Brenna, J.T.; Varamini, B.; Jensen, R.G.; Diersen-Schade, D.A.; Boettcher, J.A.; Arterburn, L.M. Docosahexaenoic and arachidonic acid concentrations in human milk worldwide. Am. J. Clin. Nutr. 2007, 85, 1457–1464. [PubMed]
6. British Nutrition Foundation. Unsaturated Fatty Acids: Nutritional and Physiological Significance; Chapman & Hall: London, UK, 1992; pp. 152–163.
7. Food and Agricultural Organization of the United Nations/World Health Organization Joint Expert Consultation. Lipids in early development. In Fats and Oils in Human Nutrition; FAO Food and Nutrition Papers; FAO: Rome, Italy, 1994; Volume 57, pp. 49–55.
8. Simopoulos, A.P.; Leaf, A.; Salem, N., Jr. Workshop on the essentiality of and recommended dietary intakes for omega-6 and omega-3 fatty acids. J. Am. Coll. Nutr. 1999, 18, 487–489. [CrossRef] [PubMed]
9. Koletzko, B.; Baker, S.; Cleghorn, G.; Neto, U.F.; Gropalan, S.; Hernell, O.; Hock, Q.S.; Jirapinyo, P.; Lonnerdal, B.; Pencharz, P., et al. Global standard for the composition of infant formula: Recommendations of an ESPAGHAN coordinated international expert group. J. Pediatr. Gastroenterol. Nutr. 2005, 41, 584–599. [CrossRef] [PubMed]
10. Lauritzen, L.; Hensen, H.S.; Jorgensen, M.H.; Michaelsen, K.F. The essentiality of long chain n-3 fatty acids in relation to development and function of the brain and retina. Prog. Lipid Res. 2001, 40, 1–94. [CrossRef]
11. Katsuki, H.; Okuda, S. Arachidonic acid as a neurotoxic and neurotrophic substance. Prog. Neurobiol. 1995, 46, 607–636. [CrossRef]
12. Crawford, M.A.; Broadhurst, C.L. The role of docosahexaenoic and the marine food web as determinants of evolution and hominid brain development: The challenges for human sustainability. Nutr. Health 2012, 21, 17–39. [CrossRef] [PubMed]
13. Bazan, N.G.; Reddy, T.S.; Bazan, H.E.P.; Birkle, D.L. Metabolism of arachidonic acid and docosahexaenoic acid in the retina. Prog. Lipid Res. 1886, 25, 595–606. [CrossRef]
14. Crawford, M.A.; Sinclair, A.J. Nutritional influences in the evolution of mammalian brain. In Lipids, Malnutrition & the Developing Brain; A Ciba Foundation Symposium: Amsterdam, The Netherlands, 1971; pp. 267–292.
15. Martinez, M. Polyunsaturated fatty acids in the developing human brain, red cells and plasma: Influence of nutrition and peroxisomal disease. In Fatty Acids and Lipids: Biological Aspects; Galli, C., Simopoulos, A.P., Tremoli, E., Eds.; Karger: Basel, Switzerland, 1994; Volume 75, pp. 70–78.
16. Dobbing, J.; Sands, J. Comparative aspects of the brain growth spurt. Early Hum. Dev. 1979, 3, 79–83. [CrossRef]
17. Su, H.-M.; Corso, T.N.; Nathanielsz, P.W.; Brenna, J.T. Linoleic acid kinetics and conversion to arachidonic acid in the pregnant and fetal baboon. J. Lipid Res. 1999, 40, 1304–1311. [PubMed]
18. Sanchez-Mejia, R.O.; Newman, J.W.; Toh, S.; Yu, G.; Zhou, G.Q.; Halabisky, B.; Cissé, M.; Scearce-Levie, K.; Cheng, I.H.; Gan, L., et al. Phospholipase A2 reduction ameliorates cognitive deficits in a mouse model of Alzheimer’s disease. Nat. Neurosci. 2008, 11, 1311–1318. [CrossRef] [PubMed]
19. Vijayaraghaven, S.; Huang, B.; Blumenthal, E.M.; Berg, D.L. Arachidonic acid as a possible negative feedback inhibitor of nicotinic acetylcholine receptors on neurons. J. Neurosci. 1995, 15, 3679–3687.
20. Williams, J.H.; Errington, M.L.; Lynch, M.A.; Bliss, T.V. Arachidonic acid induces a long term activity-dependent enhancement of synaptic transmission in the hippocampus. Nature 1989, 341, 739–742. [CrossRef] [PubMed]
21. Fukaya, T.; Gondaira, T.; Kashiyae, Y.; Kotani, S.; Ishikura, Y.; Fujikawa, S.; Kiso, Y.; Sakakibara, M. Arachidonic acid preserves hippocampal neuron membrane fluidity in senescent rats. Neurobiol. Aging 2007, 28, 1179–1186. [CrossRef] [PubMed]
22. Wang, Z.-J.; Liang, C.-L.; Li, G.-M.; Yu, C.-Y.; Yin, M. Neuroprotective effects of arachidonic acid against oxidative stress on rat hippocampal slices. Chem. Biol. Interact. 2006, 163, 207–217. [CrossRef] [PubMed]
23. Wijendran, V.; Lawrence, P.; Diau, G.-Y.; Boehm, G.; Nathanielsz, P.W.; Brenna, J.T. Significant utilization of dietary arachidonic acid is for brain adrenic acid in baboon neonates. J. Lipid Res. 2002, 43, 762–767. [PubMed]
24. Hsieh, A.T.; Anthony, J.C.; Diersen-Schade, D.A.; Rumsey, S.C.; Lawrence, P.; Li, C.; Nathanielsz, P.W.; Brenna, J.T. The influence of moderate and high dietary long chain polyunsaturated fatty acids (LCPUFA) on baboon neonate tissue fatty acids. Pediatr. Res. 2007, 61, 537–545. [CrossRef] [PubMed]
25. Yang, H.-J.; Sugiura, Y.; Ikegami, K.; Konishi, Y.; Setou, M. Axonal gradient of arachidonic acid-containing phosphatidylcholine and its dependence on actin dynamics. J. Biol. Chem. 2012, 287, 5290–5300. [CrossRef] [PubMed]
26. Bazan, N.G. The neuromessenger platelet-activation factor in plasticity and neurodegeneration. Prog. Brain Res. 1998, 118, 281–291. [PubMed]
27. Hattori, M.H.; Adachi, H.; Tsujimoto, M.; Arai, H.; Inoue, K. Miller-Dieker lissencephaly gene encodes a subunit of brain platelet-activation factor acetylhydrolase. Nature 1994, 370, 216–218. [CrossRef] [PubMed]
28. Darios, F.; Davletov, B. Omega-3 and omega-6 fatty acids stimulate cell membrane expansion by acting on syntaxin 3. Nature 2006, 440, 813–817. [CrossRef] [PubMed]
29. Darios, F.; Ruiperez, V.; Lopez, I.; Villanueva, J.; Gutierrez, L.M.; Davletov, B. ɑ -synuclein sequesters arachidonic acid to modulate SNARE-mediated exocytosis. EMBO Rep. 2010, 11, 528–533. [CrossRef] [PubMed]
30. Smart, E.J.; Graf, G.A.; McNiven, M.A.; Sessa, W.C.; Engelman, J.A.; Scherer, P.E.; Okamoto, T.; Lisanti, M.P. Caveolins, liquid-ordered domains, and signal transduction. Mol. Cell. Biol. 1999, 19, 7289–7304. [CrossRef] [PubMed]
31. Pike, L.J.; Han, X.; Chung, K.-N.; Gross, R.W. Lipid rafts are enriched in arachidonic acid and plasmmenylethanolamine and their composition is independent of caveolin-1 expression: A quantitative electrospray ionization/mass spectrometric analysis. Biochemistry 2002, 41, 2075–2088. [CrossRef] [PubMed]
32. Pike, L. Lipid rafts: Bringing order to chaos. J. Lipid Res. 2003, 44, 655–667. [CrossRef] [PubMed]
33. Lee, H.-C.; Sasaki, J.; Kubo, T.; Matsuda, S.; Nakasaki, Y.; Hattori, M.; Tanaka, F.; Udagawa, O.; Kono, N.; Itoh, T., et al. LPIAT1 regulates arachidonic acid content in phosphatidylinositol and is required for cortical lamination in mice. Mol. Biol. Cell 2012, 23, 4689–4697. [CrossRef] [PubMed]
34. 2+ mobilization of arachidonic acid. J. Biol. Chem. 1986, 261, 3501–3511. [PubMed]
35. Cao, Y.; Pearman, A.T.; Zimmermann, G.A.; McIntyre, T.M.; Prescott, S.M. Intracellular unesterified arachidonic acid signals apoptosis. PNAS 2000, 97, 11280–11285. [CrossRef] [PubMed]
36. Hicks, A.M.; DeLong, C.J.; Thomas, M.J.; Samuel, M.; Cui, Z. Unique molecular signatures of glycerophospholipid species in different rat tissues analyzed by tandem mass spectrometry. Biochim. Biophys. Acta 2006, 71, 1022–1029. [CrossRef] [PubMed]
37. Tanaka, T.; Iwawaki, D.; Sakamoto, M.; Takai, Y.; Morishige, J.-I.; Murakami, K.; Satouchi, K. Mechanisms of accumulation of aracidonate in phoshatidylinositol in yellowtail. Eur. J. Biochem. 2003, 270, 1466–1473. [CrossRef] [PubMed]
38. Jungalwala, F.B.; Evans, J.E.; McCluer, R.H. Compositional and molecular species analysis of phospholipids by high performance liquid chromatography couples with chemical ionization mass spectrometry. J. Lipid Res. 1984, 25, 738–749. [PubMed]
39. Szentpetery, Z.; Varnai, P.; Balla, T. Acute manipulation of Golgi phosphoinositides to assess their importance in cellular trafficking and signaling. PNAS 2010, 107, 8225–8230. [CrossRef] [PubMed]
40. Di Paolo, G.; De Camilli, P. Phosphoinositides in cell regulation and membrane dynamics. Nature 2006, 44, 12. [CrossRef] [PubMed]
41. 2+ inhibits mitochondrial movement in neurons by phosphatidylinositol 3-kinase activation. J. Neurosci. 2005, 25, 9507–9514. [CrossRef] [PubMed]
42. De Vos, K.J.; Sable, J.; Miller, K.E.; Sheetz, M.P. Expression of phosphatidylinositol (4,5) bisphosphate-specific pleckstrin homology domains alters direction but not the level of axonal transport of mitochondria. Mol. Biol. Cell 2002, 14, 3636–3649. [CrossRef] [PubMed]
43. Caroni, P. New EMBO members’ review: Actin cytoskeleton regulation through modulation of PI(4,5)P(2) rafts. EMBO J. 2001, 20, 4332–4336. [CrossRef] [PubMed]
44. Del Prado, M.; Villalpando, S.; Elizondo, A.; Rodriguez, M.; Demmelmair, H.; Koletzko, B. Contribution of dietary and newly formed arachidonic acid to human milk lipids in women eating a low-fat diet. Am. J. Clin. Nutr. 2001, 74, 242–247. [PubMed]
45. Crawford, M.A.; Golfetto, I.; Ghebremeskel, K.; Min, Y.; Moodley, T.; Poston, L.; Phylactos, A.; Cunnane, S.; Schmidt, W. The potential role for arachidonic and docosahexaenoic acids in protection against some central nervous system injuries in preterm infants. Lipids 2003, 38, 303–315. [CrossRef] [PubMed]
46. Larque, E.; Ruiz-Palacios, M.; Koletzko, B. Placental regulation of fetal nutrient supply. Curr. Opin. Clin. Nutr. Metab. Care 2013, 16, 292–297. [CrossRef] [PubMed]
47. Koletzko, B.; Agostini, C.; Bergmann, R.; Ritzenthaler, K.; Shamir, R. Physiological aspects of human milk lipids and implications for infant feeding: A workshop report. Acta Paediatr. 2011, 100, 1405–1415. [CrossRef] [PubMed]
48. Sinclair, A.J.; Crawford, M.A. The accumulation of arachidonate and docosahexaenoate in the developing rat brain. J. Neurochem. 1972, 19, 1753–1758. [CrossRef] [PubMed]
49. Makrides, M.; Neumann, M.; Byard, R.W.; Simmer, K.; Gibson, R.A. Fatty acid composition of brain, retina, and erythrocytes in breast- and formula-fed infants. Am. J. Clin. Nutr. 1994, 60, 189–194. [PubMed]
50. Kuipers, R.S.; Luxwolda, M.F.; Offringa, P.J.; Boersma, E.R.; Dijck-Brouwer, D.A.; Muskiet, F.A.J. Fetal intrauterine whole body linoleic, arachidonic, and docosahexaenoic acid contents and accretion rates. Prostaglandins Leukot. Essent. Fat. Acids 2011, 86, 13–20. [CrossRef] [PubMed]
51. Carver, J.D.; Benford, V.J.; Han, B.; Cantor, A.B. The relationship between age and the fatty acid composition of cerebral cortex and erythrocytes in human subjects. Brain Res. Bull. 2001, 56, 79–85. [CrossRef]
52. Salem, N.M.; Lin, Y.H.; Moriguchi, T.; Lim, S.Y.; Salem, N., Jr.; Hibbelin, J.R. Distribution of omega-6 and omega-3 polyunsaturated fatty acids in the whole rat body and 25 compartments. Prostaglandins Leukot. Essent. Fat. Acids 2015, 100, 13–20. [CrossRef] [PubMed]
53. DeMar, J.C., Jr.; DiMartino, C.; Baca, A.W.; Lefkowitz, W.; Salem, N., Jr. Effect of dietary docosahexaenoic acid on biosynthesis of docosahexaenoic acid from alpha-linolenic acid in young rats. J. Lipid Res. 2008, 49, 1963–1980. [CrossRef] [PubMed]
54. Tyburczy, C.; Kothapalli, K.S.D.; Park, W.J.; Blank, B.S.; Bradford, K.L.; Zimmer, J.P.; Butt, C.M.; Salem, N., Jr.; Brenna, J.T. Heart arachidonic acid is uniquely sensitive to dietary arachidonic acid and docosahexaenoic acid content in domestic piglets. Prostaglandins Leukot. Essent. Fat. Acids 2011, 85, 335–343. [CrossRef] [PubMed]
55. Axelrod, J. Receptor-mediated activation of phospholipase A2 and arachidonic acid release in signal transduction. Biochem. Soc. Trans. 1990, 18, 503–507. [CrossRef] [PubMed]
56. Piomelli, D. Eicosanoids in synaptic transmissions. Crit. Rev. Neurobiol. 1994, 11, 367–373.
57. Schoenheimer, R.; Rittenberg, D. Deuterium as an indicator in the study of intermediary metabolism V. The desaturation of fatty acids in the organism. J. Biol. Chem. 1936, 113, 505–510.
58. 14C in normolipidemic and hyperlipidemic humans fed linoleate diets. Am. J. Clin. Nutr. 1967, 20, 1070–1083. [PubMed]
59. Chambaz, J.; Ravel, D.; Manier, M.-C.; Pepin, D.; Mulliez, N.; Bereziat, G. Essential fatty acids interconversion in the human fetal liver. Neonatology 1985, 47, 136–140. [CrossRef]
60. El Boustani, S.; Descomps, B.; Monnier, L.; Warnant, J. In vivo conversion of dihommogamma linolenic acid into arachidonic acid in man. Prog. Lipid Res. 1986, 25, 67–71. [CrossRef]
61. Emken, E.A.; Adlof, R.O.; Rakoff, H.; Rohwedder, W.K. Metabolism of deuterium-labeled linolenic, linoleic, oleic, stearic and palmitic acid in human subjects. In Synthesis and Applications of Isotopically Labelled Compounds, Proceedings of the Third International Symposium, Innsbruck, Austria, 17–21 July 1988; Baillie, T.A., Jones, J.R., Eds.; Elsevier Science Publishers: Amsterdam, The Netherlands, 1988; pp. 713–716.
62. Emken, E.A.; Rohwedder, W.K.; Adlof, R.O.; Gulley, R.M. Metabolism in humans of cis-12, trans-15-octadecadienoic acid relative to palmitic, stearic, oleic and linoleic acids. Lipids 1987, 22, 495–504. [CrossRef] [PubMed]
63. Demmelmair, H.; von Schenck, U.; Behrendt, E.; Sauerwald, T.; Koletzko, B. Estimation of arachidonic acid synthesis in full-term neonates using natural variation of 13C content. J. Pediatr. Gastroenterol. Nutr. 1995, 21, 31–36. [CrossRef] [PubMed]
64. Salem, N., Jr.; Wegher, B.; Mena, P.; Uauy, R. Arachidonic and docosahexaenoic acids are biosynthesized from their 18-carbon precursors in human infants. Proc. Natl. Acad. Sci. USA 1996, 93, 49–54. [CrossRef] [PubMed]
65. Pawlosky, R.J.; Sprecher, H.W.; Salem, N., Jr. High sensitivity negative ion GC/MS method for detection of desaturated and chain-elongated products of deuterated linoleic and linolenic acids. J. Lipid Res. 1992, 33, 1711–1717. [PubMed]
66. Carnielli, V.P.; Wattimea, D.J.L.; Luijendijk, I.H.T.; Boerlage, A.; Degenhart, H.J.; Sauer, P.J.J. The very low weight premature infant is capable of synthesizing arachidonic and docosahexaenoic acids from linoleic and linolenic acids. Pediatr. Res. 1996, 40, 169–174. [CrossRef] [PubMed]
67. 5-20:3n-6 in newborn infants. Pediatr. Res. 2006, 60, 327–333. [CrossRef] [PubMed]
68. Sauerwald, T.U.; Hachey, D.L.; Jensen, C.L.; Chen, H.; Andersen, R.E.; Heird, W.C. Effect of dietary ɑ-linolenic intake on incorporation of docosahexaenoic and arachidonic acids into plasma phospholipids of term infants. Lipids 1996, 31, S131–S135. [CrossRef] [PubMed]
69. Carnielli, V.P.; Simonato, M.; Verlato, G.; Luijendijk, I.; De Curtis, M.; Sauer, P.J.J.; Cogo, P.E. Synthesis of long-chain polyunsaturated fatty acids in preterm newborns fed formula with long-chain polyunsaturated fatty acids. Am. J. Clin. Nutr. 2007, 86, 1323–1330. [PubMed]
70. EFSA Panel on Dietetic Products. Scientific opinion on nutrient requirements and dietary intakes on infants and young children in the European Union. EFSA J. 2013, 11, 3408.
71. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). Scientific opinion on the essential composition of infant and follow-on formulae. EFSA J. 2014, 12, 3760.
72. Birch, E.E.; Castañeda, Y.S.; Wheaton, D.H.; Birch, D.G.; Uauy, R.D.; Hoffman, D.R. Visual maturation of term infants fed long-chain polyunsaturated fatty acid-supplemented or control formula for 12 mo. Am. J. Clin. Nutr. 2005, 81, 871–879. [PubMed]
73. World Health Organization (WHO). Global Strategy on Infant and Young Child Feeding, 2002. Available online: http://www.who.int/nutrition/topics/infantfeeding_recommendation/en/ (accessed on 15 October 2015).
74. World Health Organization (WHO). Nutrient Adequacy of Exclusive Breastfeeding for the Term Infant during the First Six Months of Life, 2002. Available online: http://www.who.int/nutrition/publications/infantfeeding/9241562110/en/ (accessed on 15 October 2015).
75. American Academy of Pediatrics. Breastfeeding and the use of human milk. Pediatrics 2012, 129, e827. [CrossRef]
76. International Baby Food Action (IBFAN). The State of Breastfeeding in 33 Countries, 2010. Available online: https://www.google.co.uk/?gws_rd=ssl#q=IBFAN+33+countries (accessed on 15 October 2015).
77. U.S. Department of Agriculture, Agricultural Research Service. USDA National Nutrient Database for Standard Reference, Release 27. Nutrient Data Laboratory Home Page. 2014. Available online: http://www.ars.usda.gov/nutrientdata (accessed on 15 October 2015).
78. Centers for Disease Control and Prevention. Clinical Growth Charts, 2015. Available online: http://www.cdc.gov/growthcharts/cdccharts.htm (accessed on 19 November 2015).
79. Michaelsen, K.F.; Dewey, K.G.; Perez-Exposito, A.B. Food sources and intake of n-6 and n-3 fatty acids in low-income countries with emphasis on infants, young children (6–24 months), and pregnant and lactating women. Mater. Child Nutr. 2011, 7 (Suppl S2), 124–140. [CrossRef] [PubMed]
80. Agostoni, C. Docosahexaenoic acid (DHA): From the maternal-foetal dyad to the complementary feeding period. Early Hum. Dev. 2010, 86 (Suppl. S1), 3–6. [CrossRef] [PubMed]
81. Prentice, A.M.; Paul, A.A. Fat and energy needs of children in developing countries. Am. J. Clin. Nutr. 2000, 72, 1253S–1265S. [PubMed]
82. Barbarich, B.N.; Willows, N.D.; Wang, L.; Clandinin, M.T. Polyunsaturated fatty acids and anthropometric indices of children in rural China. Eur. J. Clin. Nutr. 2006, 60, 1100–1107. [CrossRef] [PubMed]
83. PAHO/WHO. Guiding Principles for Complementary Feeding of the Breastfed Child; PAHO/WHO: Washington, DC, USA, 2003.
84. Joshi, N.; Agho, K.E.; Dibley, M.J.; Senarath, U.; Tiwari, K. Determinants of inappropriate complementary feeding practices in young children in Nepal: Secondary data analysis of Demographic and Health Survey 2006. Mater. Child Nutr. 2012, 1, 45–59. [CrossRef] [PubMed]
85. Dutta, T.; Sywulka, S.M.; Frongillo, E.A.; Lutter, C.K. Characteristics attributed to complementary foods by caregivers in four countries of Latin America and the Caribbean. Food Nutr. Bull. 2006, 27, 316–326. [CrossRef] [PubMed]
86. Agostoni, C.; Decsi, T.; Fewtrell, M.; Goulet, O.; Kolacek, S.; Koletzko, B.; Michaelsen, K.F.; Moreno, L.; Puntis, J.; Rigo, J., et al. Complementary feeding: A commentary by the ESPGHAN Committee on Nutrition. J. Pediatr. Gastroenterol. Nutr. 2008, 46, 99–110. [CrossRef] [PubMed]
87. Schwartz, J.; Dube, K.; Alexy, U.; Kalhoff, H.; Kersting, M. PUFA and LC-PUFA intake during the first year of life: Can dietary practice achieve a guideline diet? Eur. J. Clin. Nutr. 2010, 64, 124–130. [CrossRef] [PubMed]
88. Schwartz, J.; Dube, K.; Sichert-Hellert, W.; Kannenberg, F.; Kunz, C.; Kalhoff, H.; Kersting, M. Modification of dietary polyunsaturated fatty acids via complementary food enhances n-3 long-chain polyunsaturated fatty acid synthesis in healthy infants: A double blinded randomised controlled trial. Arch. Dis. Child. 2009, 94, 876–882. [CrossRef] [PubMed]
89. Grote, V.; Verduci, E.; Scalioni, S.; Vecchi, F.; Contarini, G.; Giovannini, M.; Koletzko, B.; Agostoni, C. Breast milk composition and infant nutrient intakes during the first 12 months of life. Eur. J. Clin. Nutr. 2015, 70, 250–256. [CrossRef] [PubMed]
90. Sioen, I.; Matthys, C.; De Backer, G.; Van Camp, J.; De Henauw, S. Importance of seafood as nutrient source in the diet of Belgian adolescents. J. Hum. Nutr. Diet. 2007, 20, 580–589. [CrossRef] [PubMed]
91. Meyer, B.J.; Mann, N.J.; Lewis, J.L.; Milligan, G.C.; Sinclair, A.J.; Howe, P.R. Dietary intakes and food sources of omega-6 and omega-3 polyunsaturated fatty acids. Lipids 2003, 38, 391–398. [CrossRef] [PubMed]
92. Innis, S.M.; Vaghri, Z.; King, D.J. n-6 docosapentaenoic acid is not a predictor of low docosahexaenoic acid status in Canadian preschool children. Am. J. Clin. Nutr. 2004, 80, 768–773. [PubMed]
93. Lien, V.W.; Clamdinin, M.T. Dietary assessment of arachidonic acid and docosahexaenoic acid intake in 4–7 year-old children. J. Am. Coll. Nutr. 2009, 28, 7–15. [CrossRef] [PubMed]
94. Keim, S.A.; Branum, A.M. Dietary intake of polyunsaturated fatty acids and fish among US children 12–60 months of age. Mater. Child Health Nutr. 2015, 11, 987–998. [CrossRef] [PubMed]
95. U.S. Department of Agriculture, Agricultural Research Service. WhatWe Eat in America. 2015. Available online: http://www.ars.usda.gov/Services/docs.htm?docid=13793# (accessed on 15 October 2015).
96. Birch, E.E.; Khoury, J.C.; Berseth, C.L.; Castaneda, Y.S.; Couch, J.M.; Bean, J.; Tamer, R.; Harris, C.L.; Mitmesser, S.H.; Scalabrin, D.M. The impact of early nutrition on incidence of allergic manifestations and common respiratory illnesses in children. J. Pediatr. 2010, 156, 902–906. [CrossRef] [PubMed]
97. Calder, P.C. Polyunsaturated fatty acids and inflammation: From molecular biology to the clinic. Lipids 2003, 38, 343–352. [CrossRef] [PubMed]
98. Calder, P.C. n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am. J. Clin. Nutr. 2006, 83, 1505S–1519S. [PubMed]
99. Jones, P.J.H.; Kubow, S. Lipids, sterols, and their metabolites. In Modern Nutrition in Health and Disease; Shils, M.E., Shike, M., Ross, A.C., Caballero, B., Cousins, B., Eds.; LippincottWilliams &Wilkins: Philadelphia, PA, USA, 2006; pp. 92–122.
100. Ricciotti, E.; FitzGerald, G.A. Prostaglandins and inflammation. Arterioscler. Thromb. Vasc. Biol. 2011, 31, 986–1000. [CrossRef] [PubMed]
101. Reinhold, H.; Ahmadi, S.; Depner, U.B.; Layh, B.; Heindl, C.; Hamza, M.; Pahl, A.; Brune, K.; Narumiya, S.; Müller, U., et al. Spinal inflammatory hyperalgesia is mediated by prostaglandin E receptors of the EP2 subtype. J. Clin. Investig. 2005, 115, 673–679. [CrossRef] [PubMed]
102. Noda, M.; Kariura, Y.; Pannasch, U.; Nishikawa, K.; Wang, L.; Seike, T.; Ifuku, M.; Kosai, Y.; Wang, B.; Nolte, C., et al. Neuroprotective role of bradykinin because of the attenuation of pro-inflammatory cytokine release from activated microglia. J. Neurochem. 2007, 101, 397–410. [CrossRef] [PubMed]
103. Min, Y.; Crawford, M.A. Essential fatty acids. In The Eicosanoids; Curtis, P., Ed.; JohnWiley & Sons, Ltd.: West Sussex, UK, 2004; pp. 257–276.
104. 2 in primary rat osteoblasts. J. Biol. Chem. 1996, 271, 6666–6671. [PubMed]
105. Urade, Y.; Hayaishi, O. Prostaglandin D2 and sleep regulation. Biochem. Biophys. Acta 1999, 1436, 606–615. [CrossRef]
106. Ushikubi, F.; Sergi, E.; Sugimoto, Y.; Murata, T.; Matsuoka, T.; Kobayashi, T.; Hizaki, H.; Tuboi, K.; Katsuyama, M.; Ichikawa, A., et al. Impaired febrile response in mice lacking the prostaglandin E receptor subtype EP3. Nature 1998, 395, 281–284. [PubMed]
107. Murata, T.; Ushikubi, F.; Matsuoka, T.; Hirata, M.; Yamasaki, A.; Sugimoto, Y.; Ichikawa, A.; Aze, Y.; Tanaka, T.; Yoshida, N., et al. Altered pain perception and inflammatory response in mice lacking prostacyclin receptor. Nature 1997, 388, 678–682. [PubMed]
108. Astudillo, A.M.; Balgoma, D.; Balboa, M.A.; Balsinde, J. Dynamics of arachidonic acid mobilization by inflammatory cells. Biochim. Biophys. Acta 2012, 1821, 249–256. [CrossRef] [PubMed]
109. Bagga, D.; Wang, L.; Faris-Eisner, R.; Glaspy, J.A.; Reddy, S.T. Differential effects of prostaglandin derived from ω-6 and ω-3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion. Proc. Natl. Acad. Sci. USA 2003, 100, 1751–1756. [CrossRef] [PubMed]
110. Levy, B.D.; Clish, C.B.; Schmidt, B.; Gronert, K.; Serhan, C.N. Lipid mediator class switching during acute inflammation signals in resolution. Nat. Immunol. 2001, 2, 612–619. [CrossRef] [PubMed]
111. Samuelsson, B.; Dahlen, S.E.; Lindgren, J.A.; Rouzer, C.A.; Serhan, C.N. Leukotrienes and lipoxins—Structures, biosynthesis, and biological effects. Science 1987, 237, 1171–1176. [CrossRef] [PubMed]
112. Fredman, G.; Serhan, C.N. Specialized proresolving mediator targets for RvE1 and RvD1 in peripheral blood and mechanisms of resolution. Biochem. J. 2011, 437, 185–197. [CrossRef] [PubMed]
113. Kelley, D.S. Modulation of human and inflammatory responses by dietary fatty acids. Nutrition 2001, 17, 669–673. [CrossRef]
114. Calder, P.C.; Kew, S. The immune system: A target for functional foods? Br. J. Nutr. 2002, 88 (Suppl S2), S165–S176. [CrossRef] [PubMed]
115. Lentz, A.K.; Feezor, R.J. Principles of immunology. Nutr. Clin. Pract. 2003, 18, 451–460. [CrossRef] [PubMed]
116. Mahadevappa, V.G.; Holub, B.J. The molecular species composition of individual diacyl phospholipids in human platelets. Biochim. Biophys. Acta 1982, 713, 73–79. [CrossRef]
117. Kaushansky, K. Lineage-specific hematopoietic growth factors. N. Engl. J. Med. 2006, 354, 2034–2045. [CrossRef] [PubMed]
118. Semple, J.W.; Italiano, J.E., Jr.; Freedman, J. Platelets and the immune system. Nature 2011, 11, 264–274.
119. Tamagawa-Mineoka, R. Important roles of platelets as immune cells in the skin. J. Dermatol. Sci. 2015, 77, 93–101. [CrossRef] [PubMed]
120. Martin, C.R.; DaSilva, D.A.; Cluette-Brown, J.E.; DiMonda, C.; Hamill, A.; Bhutta, A.Q.; Coronel, E.; Wilschanski, M.; Stephens, A.J.; Driscoll, D.F., et al. Decreased postnatal docosahexaenoic and arachidonic acid blood levels in premature infants are associated with neonatal morbidities. J. Pediatr. 2011, 159, 743–749. [CrossRef] [PubMed]
121. Lands, W.F.; LeTellier, P.R.; Rome, L.H.; Vanderhoek, J.Y. Inhibition of prostaglandin biosynthesis. Adv. Biosci. 1973, 9, 15–227.
122. Vane, J.R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature 1971, 231, 232–235. [CrossRef]
123. Hormones. Available online: http://www.medicinenet.com/script/main/art.asp?articlekey=3783 (accessed on 6 February 2016).
124. McMurray, W.C. A Synopsis of Human Biochemistry; Harper and Row Publishers: New York, NY, USA, 1982; pp. 193–199.
125. Bowen, R.A. Hormone Chemistry, Synthesis and Elimination. Available online: http://www.vivo.colostate.edu/hbooks/pathphys/endocrine/basics/chem.html (accessed on 15 October 2015).
126. Thorner, M.O.; Vance, M.L.; Hartman, M.L.; Holl, R.W.; Evans, W.S.; Veldhuis, J.D.; Van Cauter, E.; Copinschi, G.; Bowers, C.Y. Physiological role of somatostatin on growth hormone regulation in humans. Metabolism 1990, 39, 40–42. [CrossRef]
127. 2 dependent proliferation of growth plate chondrocytes. Arthritis Res. Ther. 2006, 8, R78. [CrossRef] [PubMed]
128. Boyan, B.D.; Sylvia, V.L.; Dean, D.D.; Del Toro, F.; Schwartz, Z. Differential regulation of growth plate chondrocytes by 1alpha,25-(OH)2D3 and 24R,25-(OH)2D3 involves cell-maturation-specific membrane-receptor-activated phospholipid metabolism. Crit. Rev. Oral Biol. Med. 2002, 13, 143–154. [CrossRef] [PubMed]
129. Specker, B.; Binkley, T. Randomized trial of physical activity and calcium supplementation on bone mineral content in 3- to 5-year-old children. J. Bone Miner. Res. 2003, 418, 885–892. [CrossRef] [PubMed]
130. Specker, B.L.; Mulligan, L.; Ho, M. Longitudinal study of calcium intake, physical activity, and bone mineral content in infants 6–18 months of age. J. Bone Miner. Res. 1999, 14, 569–576. [CrossRef] [PubMed]
131. Del Toro, F., Jr.; Sylvia, V.L.; Schubkegel, S.R.; Campos, R.; Dean, D.D.; Boyan, B.D.; Schwartz, Z. Characterization of prostaglandin E(2) receptors and their role in 24,25-(OH)(2)D(3)-mediated effects on resting zone chondrocytes. J. Cell Physiol. 2000, 182, 196–208. [CrossRef]
132. 2. Steroids 1999, 64, 129–136. [PubMed]
133. Schwartz, Z.; Sylvia, V.L.; Curry, D.; Luna, M.H.; Dean, D.D.; Boyan, B.D. Arachidonic acid directly mediates the rapid effects of 24,25-dihydroxyvitamin D3 via protein kinase C and indirectly through prostaglandin production in resting zone chondrocytes. Endocrinology 1999, 140, 2991–3002. [CrossRef] [PubMed]
134. Sylvia, V.L.; Schwartz, Z.; Curry, D.B.; Chang, Z.; Dean, D.D.; Boyan, B.D. 1,25(OH)2D3 regulates protein kinase C activity through two phospholipid-dependent pathways involving phospholipase A2 and phospholipase C in growth zone chondrocytes. J. Bone Miner. Res. 1998, 13, 559–569. [CrossRef] [PubMed]
135. Kosher, R.A.; Walker, K.H. The effect of prostaglandins on in vitro limb cartilage differentiation. Exp. Cell Res. 1983, 145, 145–153. [CrossRef]
136. Copray, J.C.; Jansen, H.W. Cyclic nucleotides and growth regulation of the mandibular condylar cartilage of the rat in vitro. Arch. Oral Biol. 1985, 30, 749–752. [CrossRef]
137. 2 inhibits chondrocyte differentiation through PKA and PKC signaling. Exp. Cell Res. 2004, 300, 159–169. [CrossRef] [PubMed]
138. Raisz, L.G. Prostaglandins and bone: Physiology and pathophysiology. Osteoarthr. Cartil. 1999, 7, 419–421. [CrossRef] [PubMed]
139. Suzawa, T.; Miyaura, C.; Inada, M.; Maruyama, T.; Sugimoto, Y.; Ushikubi, F.; Ichikawa, A.; Narumiya, S.; Suda, T. The role of prostaglandin E receptor subtypes (EP1, EP2, EP3, and EP4) in bone resorption: An analysis using specific agonists for the respective EPs. Endocrinology 2000, 141, 1554–1559. [CrossRef] [PubMed]
140. Baylink, D.J.; Finkelman, R.D.; Mohan, S. Growth factors to stimulate bone formation. J. Bone Min. Res. 1993, 8, S565–S572. [CrossRef] [PubMed]
141. 2 agonist induces bone healing. PNAS 2003, 100, 6736–6740. [CrossRef] [PubMed]
142. 2 receptor (EP4) selective agonist (ONO-4819.CD) accelerates bone repair of femoral cortex after drill-hole injury associated with local upregulation of bone turnover in mature rats. Bone 2004, 34, 940–943. [CrossRef] [PubMed]
143. 2. Bone 1987, 8, 171–178. [CrossRef]
144. Agas, D.; Marchetti, L.; Hurley, M.M.; Sabbieti, D. Prostaglandin F2ɑ: A bone remodeling mediator. J. Cell. Physiol. 2013, 228, 25–29. [CrossRef] [PubMed]
145. Galea, G.L.; Meakin, L.B.; Williams, C.M.; Hulin-Curtis, S.L.; Lanyon, L.E.; Poole, A.W.; Price, J.S. Protein kinase Cɑ (PKC ɑ) regulates bone architecture and osteoblast activity. J. Biol. Chem. 2014, 289, 25509–25522. [CrossRef] [PubMed]
146. Zaman, G.; Sunters, A.; Galea, G.L.; Javaheri, B.; Saxon, L.K.; Moustafa, A.; Armstrong, V.J.; Price, J.S.; Lanyon, L.E. Loading-related regulation of transcription factor EGR2/Krox-20 in bone cells is ERK1/2 protein-mediated and prostaglandin, Wnt-signaling pathway-, and insulin-like growth factor-I axis-dependent. J. Biol. Chem. 2012, 287, 3946–3962. [CrossRef] [PubMed]
147. Kido, S.; Kuriwaka-Kido, R.; Umino-Miyatani, Y.; Endo, I.; Inoue, D.; Taniguchi, H.; Inoue, Y.; Imamura, T.; Matsumoto, T. Mechanical stress activates Smad pathway through PKCδ to enhance interleukin-11 gene transcription in osteoblasts. PLoS ONE 2010, 5, e13090. [CrossRef] [PubMed]
148. Nakura, A.; Higuchi, C.; Yoshida, K.; Yoshikawa, H. PkCɑ suppresses osteoblastic differentiation. Bone 2011, 48, 476–484. [CrossRef] [PubMed]
149. Weiler, H.A.; Fitzpatrick-Wong, S. Dietary long-chain polyunsaturated fatty acids minimize dexamethasoneinduced reductions in arachidonic acid status but not bone mineral content in piglets. Pediatr. Res. 2002, 51, 282–289. [CrossRef] [PubMed]
150. Blanaru, J.L.; Kohut, J.R.; Fitzpatrick-Wong, S.C.; Weiler, H.A. Dose response of bone mass to dietary arachidonic acid in piglets fed cow milk-based formula. Am. J. Clin. Nutr. 2004, 79, 139–147. [PubMed]
151. 2 in osteoblast cells. Endocrinology 1996, 137, 2375–2382. [PubMed]
152. Almaden, Y.; Canalejo, A.; Ballesteros, E.; Anon, G.; Rodriguez, M. Effect of high extracellular phosphate concentration on arachidonic acid production by parathyroid tissue in vitro. J. Am. Soc. Nephrol. 2000, 11, 1712–1718. [PubMed]
153. Klein-Nulend, J.; Burger, E.H.; Semeins, C.M.; Raisz, L.G.; Pilbeam, C.C. Pulsating fluid flow stimulates prostaglandin release and inducible prostaglandin G/H synthase mRNA expression in primary mouse bone cells. J. Bone Miner. Res. 1997, 12, 45–51. [CrossRef] [PubMed]
154. Weiler, H.A. Dietary supplementation of arachidonic acid is associated with higher whole body weight and bone mineral density in growing pigs. Pediatr. Res. 2000, 47, 692–697. [CrossRef] [PubMed]
155. Weiler, H.; Fitzpatrick-Wong, S.; Schellenberg, J.; McCloy, U.; Veitch, R.; Kovacs, H.; Kohut, J.; Kin Yuen, C. Maternal and cord blood long-chain polyunsaturated fatty acids are predictive of bone mass at birth in healthy term-born infants. Pediatr. Res. 2005, 58, 1254–1258. [CrossRef] [PubMed]
156. Akatsu, T.; Takahashi, N.; Udagawa, N.; Imamura, K.; Yamaguchi, A.; Sato, K.; Nagata, N.; Suda, T. Role of prostaglandins in interleukin-1-induced bone resorption in mice in vitro. J. Bone Miner. Res. 1991, 6, 183–189. [CrossRef] [PubMed]
157. 2 on osteoclastogenesis via the OPG/RANKL/RANK system. Ann. N. Y. Acad. Sci. 2006, 1068, 225–233. [CrossRef] [PubMed]
158. Zhang, X.; Schwarz, E.M.; Young, D.A.; Puzas, J.E.; Rosier, R.N.; O’Keefe, R.J. Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair. J. Clin. Investig. 2002, 109, 1405–1415. [CrossRef] [PubMed]
159. 2 stimulates bone sialoprotein (BSP) expression through cAMP and fibroblast growth factor 2 response elements in the proximal promoter of the rat BSP gene. J. Biol. Chem. 2003, 278, 28659–28667. [CrossRef] [PubMed]
160. Cherian, P.P.; Cheng, B.; Gu, S.; Sprague, E.; Bonewald, L.F.; Jiang, J.X. Effects of mechanical strain on the function of Gap junctions in osteocytes are mediated through the prostaglandin EP2 receptor. J. Biol. Chem. 2003, 278, 43146–43156. [CrossRef] [PubMed]
161. 2-mediated bone resorption associated with inflammation. J. Exp. Med. 2003, 197, 1303–1310. [CrossRef] [PubMed]
162. Boswell, K.; Koskelo, E.-K.; Carl, L.; Glaze, S.; Hensen, D.J.; Williams, K.D.; Kyle, D.J. Preclinical evaluation of single-cell oils that are highly enriched with arachidonic acid and docosahexaenoic acid. Food Chem. Toxicol. 1996, 34, 585–593. [CrossRef]
163. Suarez, A.; del Carmen Ramirez, M.; Faus, M.J.; Gil, A. Dietary long-chain polyunsaturated fatty acids influence tissue fatty acid composition in rats at weaning. J. Nutr. 1996, 126, 887–897. [PubMed]
164. De la Presa-Owens, S.; Innis, S.M.; Rioux, F.M. Addition of triglycerides with arachidonic acid or docosahexaenoic acid to infant formula has tissue- and lipid class-specific effects on fatty acids and hepatic desaturase activities in formula-fed piglets. J. Nutr. 1998, 128, 1376–1384. [PubMed]
165. Baur, L.A.; O’Connor, J.; Pan, D.A.; Kriketos, A.D.; Storlien, L.H. The fatty acid composition of skeletal muscle membrane phospholipid: Its relationship with the type of feeding and plasma levels in young children. Metabolism 1998, 47, 106–112. [CrossRef]
166. 2+ release in isolated fibers of adult mouse skeletal muscle. J. Gen. Physiol. 2012, 140, 235–241. [CrossRef] [PubMed]
167. 2+ release in skeletal muscle by activation of a voltage-sensing phosphatase. J. Gen. Physiol. 2015, 145, 315–330. [CrossRef] [PubMed]
168. Ohizumi, Y.; Hirata, Y.; Suzuki, A.; Kobayashi, M. Two novel types of calcium release from skeletal sarcoplasmic reticulum by phosphatidylinositol 4,5 biphosphate. Can. J. Physiol. Pharmacol. 1999, 77, 276–285. [CrossRef] [PubMed]
169. Sandow, A. Excitation-contraction coupling in muscular response. Yale J. Biol. Med. 1952, 25, 176–201. [PubMed]
170. 2+ ions in excitation-contraction coupling of skeletal muscle fibres. Biochim. Biophys. Acta 1995, 1241, 59–116. [CrossRef]
171. Kobayashi, M.; Muroyama, A.; Ohizumi, Y. Phosphatidylinositol 4,5-bisphosphate enhances calcium release from sarcoplasmic reticulum of skeletal muscle. Biochem. Biophys. Res. Commun. 1989, 29, 1487–1491. [CrossRef]
172. Ghigo, A.; Perino, A.; Hirsch, E. Phosphoinositides and cardiac function. In Phosphoinositides and Disease, Current Topics in Microbiology and Immunology; Falasca, M., Ed.; Springer Science + Business Media: Dordrecht, The Netherlands, 2012; pp. 43–60.
173. 2ɑ influence rates of protein turnover in skeletal and cardiac muscle. J. Biol. Chem. 1982, 25, 1632–1638.
174. 2 induces transcription of skeletal mass regulators interleukin-6 and muscle RING finger-1 in humans. Prostaglandins Leukot. Essent. Fat. Acids 2013, 88, 361–364. [CrossRef] [PubMed]
175. Kuipers, R.S.; Luxwolda, M.F.; Dijck-Brouwer, J.; Muskiet, F.A.J. Intrauterine, postpartum and adult relationships between arachidonic acid (AA) and docosahexaenoic acid (DHA). Prostaglandins Leukot. Essent. Fat. Acids 2011, 85, 245–252. [CrossRef] [PubMed]
176. Luxwolda, M.F.; Kuipers, R.S.; Sango, W.S.; Kwesigabo, G.; Dijck-Brouwer, D.A.J.; Muskiet, F.A.J. A maternal erythrocyte DHA content of approximately 6 g% is the DHA status at which intrauterine DHA biomagnifications turns into bioattenuation and postnatal infant DHA equilibrium is reached. Eur. J. Nutr. 2012, 51, 665–675. [CrossRef] [PubMed]
177. Carlson, S.E.; Werkman, S.H.; Peoples, J.M.; Cooke, R.J.; Tolley, E.A. Arachidonic acid status correlates with first year of growth in preterm infants. Proc. Natl. Acad. Sci. USA 1993, 90, 1073–1077. [CrossRef] [PubMed]
178. Clandinin, M.T. Brain development and assessing the supply of polyunsaturated fatty acids. Lipids 1999, 34, 131–137. [CrossRef] [PubMed]
179. Clandinin, M.T.; Chappell, J.E.; Leong, S.; Heim, T.; Sayer, P.R.; Chance, G.W. Intrauterine fatty acid accretion in infant brain: Implications for fatty acid requirements. Early Hum. Dev. 1980, 4, 121–129. [CrossRef]
180. Cunnane, S. Problems with essential fatty acids: Time for a new paradigm? Prog. Lipid Res. 2003, 42, 544–568. [CrossRef]
181. Stoffel, W.; Holz, B.; Jenke, B.; Binczek, E.; Günter, R.H.; Kiss, C.; Karakesisoglou, I.; Thevis, M.; Weber, A.A.; Arnhold, S., et al. D6-desaturase (FADS2) deficiency unveils role of !3- and !6-polyunsaturated fatty acids. EMBO J. 2008, 27, 2281–2292. [CrossRef] [PubMed]
182. Stroud, C.K.; Nara, T.Y.; Roqueta-Rivera, M.; Radlowski, E.C.; Lawrence, P.; Zhang, Y.; Cho, B.H.; Segre, M.; Hess, R.A.; Brenna, J.T., et al. Disruption of FADS2 gene in mice impairs male reproduction and causes dermal and intestinal ulceration. J. Lipid Res. 2009, 50, 1870–1880. [CrossRef] [PubMed]
183. Mohrhauer, H.; Holman, R.T. The effect of dose level of essential fatty acids upon fatty acid composition of the rat liver. J. Lipid Res. 1963, 4, 151–159. [PubMed]
184. Prottey, C. Essential fatty acids and the skin. Br. J. Dermatol. 1976, 94, 579–587. [CrossRef] [PubMed]
185. Hansen, H.S.; Jensen, B. Essential function of linoleic acid esterified in acylglucosylceramide and acylceramide in maintaining the epiderma; water permeability barrier. Evidence from feeding studies with oleate, linoleate, arachidonate, columbinate and alpha-linolenate. Biochem. Biophys. Acta 1985, 834, 357–363. [CrossRef]
186. Hartop, P.J.; Prottey, C. Changes in transepidermal water loss and the composition of epidermal lecithin after application of pure fatty acid triglycerides to the skin of essential fatty acid-deficient rats. Br. J. Dermatol. 1976, 95, 255–264. [CrossRef] [PubMed]
187. Bertram, T.A. Gastrointestinal tract. In Handbook of Toxicologic Pathology; Haschek,W.M., Rousseaux, C.G., Wallig, M., Eds.; Academic Press: San Diego, CA, USA, 2002; pp. 121–186.
188. Miller, C.C.; Ziboh, V.A. Induction of epidermal hyperproliferation by topical n-3 polyunsaturated fatty acids on guinea pig skin linked to decreased levels of 13-hydroxyoctadecadienoic acid (13-Hode). J. Investig. Dermatol. 1990, 94, 353–358. [CrossRef] [PubMed]
189. Cho, H.P.; Nakamura, T.; Clarke, S.D. Cloning, expression, and nutritional regulation of the mammalian delta-6 desaturate. J. Biol. Chem. 1999, 274, 471–477. [CrossRef] [PubMed]
190. Williard, D.E.; Nwankwo, J.O.; Kaduce, T.L.; Harmon, S.D.; Irons, M.; Moser, H.W.; Raymond, G.V.; Spector, A.A. Identification of a fatty acid delta6-desaturase deficiency in human skin fibroblasts. J. Lipid Res. 2001, 42, 501–508. [PubMed]
191. Fan, Y-Y.; Monk, J.M.; Hou, T.Y.; Callway, E.; Vincent, L.; Weeks, B.; Yang, P.; Chapkin, R.S. Characterization of an arachidonic acid-deficient (Fads1 knockout) mouse model. J. Lipid Res. 2012, 53, 1287–1295.
192. Hatanaka, E.; Yasuda, H.; Harauma, A.; Watanabe, J.; Konishi, Y.; Nakamura, M.; Salem, N., Jr.; Moriguchi, T. The Effects of Arachidonic Acid and/or Docosahexaenoic Acid on the Brain Development Using Artificial Rearing of Delta-6-Desaturase Knockout Mice. In Proceedings of the Asian Conference of Nutrition, Yokohama, Japan, 14–18 May 2015.
193. Tian, C.; Fan, C.; Liu, X.; Xu, F.; Qi, K. Brain histological changes in young mice submitted to diets with different ratios of n-6/n-3 polyunsaturated fatty acids during maternal pregnancy and lactation. Clin. Nutr. 2011, 30, 659–667. [CrossRef] [PubMed]
194. Nguyen, L.N.; Ma, D.; Shui, G.; Wong, P.; Cazenave-Gassiot, A.; Zhang, X.; Wenk, M.R.; Goh, E.L.K.; Silver, D.L. Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid. Nature 2014, 509, 503–506. [CrossRef] [PubMed]
195. Berger, J.H.; Charron, M.J.; Silver, D.L. Major Facilitator superfamily domain-containing protein 2a (MFSD2A) has roles in body growth, motor function, and lipid metabolism. PLoS ONE 2012, 7, e50629. [CrossRef] [PubMed]
196. 2 production but have different effects on lymphocyte functions and cell-mediated immunity. Lipids 1998, 33, 171–180. [CrossRef] [PubMed]
197. Jolly, C.A.; Jiang, Y-H.; Chapkin, R.S.; McMurray, D.N. Dietary (n-3) polyunsaturated fatty acids suppress murine lymphoproliferation, interleukin-2 secretion, and the formation of diacylglycerol and cereamide. J. Nutr. 1997, 127, 37–43. [PubMed]
198. Kelley, D.S.; Taylor, P.C.; Nelson, G.J.; Schmidt, P.C.; Mackey, B.E.; Kyle, D. Effects of dietary arachidonic acid on human immune response. Lipids 1997, 32, 449–456. [CrossRef] [PubMed]
199. Blikslager, A.T.; Moeser, A.J.; Gookin, J.L.; Jones, S.L.; Odle, J. Restoration of barrier function in injured intestinal mucosa. Physiol. Rev. 2007, 87, 545–564. [CrossRef] [PubMed]
200. Ferrer, R.; Moreno, J.J. Role of eicosanoids on intestinal epithelial homeostatis. Biochem. Pharmacol. 2010, 80, 431–438. [CrossRef] [PubMed]
201. Jacobi, S.K.; Moeser, A.J.; Corl, B.A.; Harrell, R.J.; Bilksager, A.T. Dietary long-chain PUFA enhances acute repair of ischemia-injured intestine of suckling pigs. J. Nutr. 2012, 142, 1266–1271. [CrossRef] [PubMed]
202. Le, H.D.; Meisel, J.A.; de Meijer, V.E.; Fallon, E.M.; Gura, K.M.; Nose, V.; Bistrian, B.R.; Puder, M. Docosahexaenoic acid and arachidonic acid prevent essential fatty acid deficiency and hepatic steatosis. J. Parenter. Enter. Nutr. 2012, 36, 431–441. [CrossRef] [PubMed]
203. Bassaganya-Riera, J.; Guri, A.J.; Noble, A.M.; Reynolds, K.A.; King, J.; Wood, C.M.; Ashby, M.; Rai, D.; Hontecillas, R. Arachidonic acid- and docosahexaenoic acid-enriched formulas modulate antigen-specific T cell responses to influenza virus in neonatal piglets. Am. J. Clin. Nutr. 2007, 85, 824–836. [PubMed]
204. Weisinger, H.S.; Vingrys, A.J.; Sinclair, A.J. The effect of docosahexaenoic acid on the electroretinogram of the guinea pig. Lipids 1996, 31, 65–70. [CrossRef] [PubMed]
205. Champoux, M.; Hibbeln, J.R.; Shannon, C.; Majchrzak, S.; Suomi, S.J.; Salem, N., Jr.; Higley, J.D. Fatty acid formula supplementation and neuromotor development in rhesus monkey neonates. Pediatr. Res. 2002, 51, 273–281. [CrossRef] [PubMed]
206. Ikemoto, A.; Ohishi, M.; Sato, Y.; Hata, N.; Misawa, Y.; Fujii, Y.; Okuyama, H. Reversibility of n-3 fatty acid deficiency-induced alterations of learning behavior in the rat: Level of n-6 fatty acids as another factor. J. Lipid Res. 2001, 42, 1655–1663. [PubMed]
207. Wainwright, P.E.; Xing, H.-C.; Mutsaers, L.; McCutcheon, D.; Kyle, D. Arachidonic acid offsets the effects on mouse brain and behavior of a diet with a low (n-6):(n-3) ratio and very high levels of docosahexaenoic acid. J. Nutr. 1997, 127, 184–193. [PubMed]
208. Wainwright, P.E.; Xing, H.-C.; Ward, G.R.; Huang, Y.-S.; Bobik, E.; Auestad, N.; Montalto, M.Water maze performance is unaffected in artificially reared rats fed diets supplemented with arachidonic acid and docosahexaenoic acid. J. Nutr. 1999, 129, 1079–1089. [PubMed]
209. Wainwright, P.E.; Huang, Y.S.; Bulman-Fleming, B.; Dalby, B.; Mills, D.E.; Redden, P.; McCutcheon, D. The effect of dietary n-3/n-6 ration on brain development in the mouse: A dose response study with long-chain n-3 fatty acids. Lipids 1992, 27, 98–103. [CrossRef] [PubMed]
210. Min, Y.; Lowry, C.; Ghebremeskel, K.; Thomas, B.; Offley-Shore, B.; Crawford, M. Unfavorable effect of type 1 and type 2 diabetes on maternal and fetal essential fatty acid status: A potential marker of fetal insulin resistance. Am. J. Clin. Nutr. 2005, 82, 1162–1168. [PubMed]
211. Siddappa, A.M.; Georgieff, M.K.; Wewerka, S.; Worwa, C.; Nelson, C.A.; Deregnier, R.A. Iron deficiency alters auditory recognition memory in newborn infants of diabetic mothers. Pediatr. Res. 2004, 55, 1034–1041. [CrossRef] [PubMed]
212. DeBoer, T.; Wewerka, S.; Bauer, P.J.; Geogieff, M.K.; Nelson, C.A. Explicit memory performance in infants of diabetic mothers at 1 year of age. Dev. Med. Child Neurol. 2005, 47, 525–531. [CrossRef] [PubMed]
213. Holman, R.T.; Johnson, S.B.; Gerrand, J.M.; Mauer, S.M.; Kupcho-Sandberg, S.; Brown, D.M. Arachidonic acid deficiency in streptozotocin-induced diabetes. Proc. Natl. Acad. Sci. USA 1983, 80, 1375–2379. [CrossRef]
214. Hadders-Algra, M. Prenatal long-chain polyunsaturated fatty acid status: The importance of a balanced intake of docosahexaenoic acid and arachidonic acid. J. Perinat. Med. 2008, 36, 101–109. [CrossRef] [PubMed]
215. Clandinin, M.T.; Chappell, J.E.; Leong, S.; Heim, T.; Sayer, P.R.; Chance, G.W. Extrauterine fatty acid accretion in infant brain: Implications for fatty acid requirements. Early Hum. Dev. 1980, 4, 131–138. [CrossRef]
216. Zhao, J.; Bigio, M.R.; Weiler, H.A. Maternal arachidonic acid supplementation improves neurodevelopment in young adult offspring from rat dams with and without diabetes. Prostaglandins Leukot Essent. Fat. Acids 2011, 84, 63–70. [CrossRef] [PubMed]
217. Amusquivar, E.; Ruperez, F.J.; Barbas, C.; Herrera, E. Low arachidonic acid rather than ɑ -tocopherol is responsible for the delayed postnatal development of offspring of rats fed fish oil instead of olive oil during pregnancy and lactation. J. Nutr. 2000, 13, 2855–2865.
218. Haubner, L.; Sullivan, J.; Ashmeade, T.; Saste, M.; Wiener, D.; Carver, J. The effects of maternal dietary docosahexaenoic acid intake on rat pup myelin and the auditory startle response. Dev. Neurosci. 2007, 29, 460–467. [CrossRef] [PubMed]
219. Elsherbiny, M.E.; Goruk, S.; Monckton, E.A.; Richard, C.; Brun, M.; Emara, M.; Field, C.J.; Godbout, R. Long-term effect of docosahexaenoic acid feeding on lipid composition and brain fatty acid-binding protein expression in rats. Nutrients 2015, 7, 8802–8817. [CrossRef] [PubMed]
220. Maekawa, M.; Takashima, N.; Matsumata, M.; Ikegami, S.; Kontani, M.; Hara, Y.; Kawashima, H.; Owada, Y.; Kiso, Y.; Yoshikawa, T., et al. Arachidonic acid drives postnatal neurogenesis and elicits a beneficial effect on prepulse inhibition, a biological trait of psychiatric illnesses. PLoS ONE 2009, 4, e5085. [CrossRef] [PubMed]
221. Fleith, M.; Clandinin, T. Dietary PUFA for preterm and term infants: Review of clinical studies. Crit. Rev. Food Sci. Nutr. 2005, 3, 205–229. [CrossRef]
222. Jensen, C.L.; Prager, T.C.; Fraley, J.K.; Chen, H.; Anderson, R.E.; Heird, W.C. Effect of dietary linoleic/alpha-linolenic acid ratio on growth and visual function of term infants. J. Pediatr. 1997, 131, 200–209. [CrossRef]
223. Makrides, M.; Neumann, M.A.; Jeffrey, B.; Lien, E.L.; Gibson, R.A. A randomized trial of different ratios of linoleic to alpha-linolenic acid in the diet of term infants: Effect on visual function and growth. Am. J. Clin. Nutr. 2000, 71, 120–129. [PubMed]
224. Makrides, M.; Neumann, M.A.; Simmer, K.; Gibson, R.A. Erythrocyte fatty acids of term infants fed either breast milk, standard formula, or formula supplemented with long-chain polyunsaturates. Lipids 1995, 30, 941–948. [CrossRef] [PubMed]
225. Makrides, M.; Neumann, M.A.; Simmer, K.; Pater, J.; Gibson, R. Are long-chain polyunsaturated fatty acids essential nutrients in infancy? Lancet 1995, 345, 1463–1468. [CrossRef]
226. Makrides, M.; Neumann, M.A.; Simmer, K.; Gibson, R.A. Dietary long-chain polyunsaturated fatty acids do not influence growth in term infants: A randomized clinical trial. Pediatrics 1999, 104, 468–475. [CrossRef] [PubMed]
227. Scott, D.T.; Janowsky, J.S.; Carroll, R.E.; Taylor, J.A.; Auestad, N.; Montalto, M.B. Formula supplementation with long-chain polyunsaturated fatty acids: Are there developmental benefits? Pediatrics 1998, 102, e59. [CrossRef] [PubMed]
228. Gibson, R.A.; Neumann, M.; Makrides, M. The effects of diets rich in docosahexaenoic acid and/or gamma-linolenic acid on plasma fatty acid profiles in term infants. In Lipids in Infant Nutrition; Huang, Y.S., Sinclair, A., Eds.; AOCS Press: Champaign, IL, USA, 1998; pp. 19–28.
229. Simmer, K. Longchain polyunsaturated fatty acid supplementation in infants born at term. Cochrane Database Syst. Rev. 2001, 4. [CrossRef]
230. Uauy, R.D.; Hoffman, D.R.; Birch, E.E.; Birch, D.G.; Jameson, D.M.; Tyson, J.E. Safety and efficacy of omega-3 fatty acids in the nutrition of very low birth weight infants: Soy oil and marine oil supplementation of formula. J. Pediatr. 1994, 124, 612–620. [CrossRef]
231. Clandinin, M.T.; Van Aerde, J.E.; Parrott, A.; Field, C.J.; Euler, A.R.; Lien, E.L. Assessment of the efficacious dose of arachidonic and docosahexaenoic acids in preterm infant formula: Fatty acid composition of erythrocyte membrane lipids. Pediatr. Res. 1997, 42, 819–825. [CrossRef] [PubMed]
232. Vanderhoof, J.; Gross, S.; Hegyi, T.; Clandinin, T.; Porcelli, P.; DeCristofaro, J.; Rhodes, T.; Tsang, R.; Shattuck, K.; Cowett, R., et al. Evaluation of a long-chain polyunsaturated fatty acid supplemented formula on growth, tolerance, and plasma lipids in preterm infants up to 48 weeks postconceptional age. J. Pediatr. Gastr. Nutr. 1999, 29, 318–326. [CrossRef]
233. Vanderhoof, J.; Gross, S.; Hegyi, T. A multicenter long-term safety and efficacy trial of preterm formula with long-chain polyunsaturated fatty acids. J. Pediatr. Gastr. Nutr. 2000, 31, 121–127. [CrossRef]
234. Food and Drug Administration. Agency Response Letter. GRAS Notice No. GRN 000041; U.S. Food and Drug Administration, Department of Health and Human Services: Washington, DC, USA, 2001.
235. Health Canada. Novel Food Decision, DHASCO and ARASCO Oils as Sources of Docosahexaenoic (DHA) and Arachidonic Acid (ARA) in Human Milk Substitutes, 2002. Available online: http://www.novelfoods.gc.ca (accessed on 19 October 2015).
236. Ryan, A.S.; Zeller, S.; Nelson, E.B. Safety evaluation of single cell oils and the regulatory requirements for use as food ingredients. In Single Cell Oils. Microbial and Algal Oil, 2nd ed.; Cohen, Z., Ratledge, C., Eds.; AOCS Press: Urbana, IL, USA, 2010; pp. 317–350.
237. Dobbing, J. Vulnerable periods in developing brain. In Brain, Behavior, and Iron in the Infant Diet; Dobbing, J., Ed.; Springer-Verlag: London, UK, 1990; pp. 1–25.
238. Uauy, R.D.; Birch, D.G.; Birch, E.E.; Hoffman, D.R.; Tyson, J.E. Effect of dietary essential !-3 fatty acids on retinal and brain development in premature infants. In Essential Fatty Acids and Eicosanoids; Sinclair, A., Gibson, E., Eds.; American Oil Chemists’ Society: Champaign, IL, USA, 1992; pp. 197–202.
239. Uauy, R.D.; Treen, M.; Hoffman, D.R. Essential fatty acid metabolism and requirements during development. Semin. Perinatol. 1989, 13, 118–130. [PubMed]
240. Carlson, S.E.; Crooke, R.J.; Werkman, S.H.; Tolley, E.A. First year growth of preterm infants fed standard compared to marine oil n-3 supplemented formula. Lipids 1992, 27, 901–907. [CrossRef] [PubMed]
241. Carlson, S.E.; Werkman, S.H. A randomized trial of visual attention of preterm infants fed docosahexaenoic acid until two months. Lipids 1996, 31, 85–90. [CrossRef] [PubMed]
242. Diersen-Schade, D.A.; Hansen, J.W.; Harris, C.L.; Merkel, K.L.; Wisont, K.D.; Boettcher, J.A. Docosahexaenoic acid plus arachidonic acid enhance preterm infant growth. In Essential Fatty Acids and Eicosanoids: Invited Papers from the Fourth International Congress; Riemersma, R.A., Armstrona, R., Kelly, W., Wilson, R., Eds.; AOCS Press: Champaign, IL, USA, 1998; pp. 123–127.
243. Ryan, A.S.; Montalto, M.B.; Groh-Wargo, S.; Mimouni, F.; Sentipal-Walerius, J.; Doyle, J.; Siegman, J.; Thomas, A.J. Effect of DHA-containing formula on growth of preterm infants to 59 weeks postmenstrual age. Am. J. Hum. Biol. 1999, 11, 457–467. [CrossRef]
244. Carlson, S.E.; Werkman, S.H.; Peeples, J.M.; Wilson, W.M. Long-chain fatty acids and early visual and cognitive development of preterm infants. Eur. J. Clin. Nutr. 1994, 48, S27–S30. [PubMed]
245. Werkman, S.H.; Carlson, S.E. A randomized trial of visual attention of preterm infants fed docosahexaenoic acid until nine months. Lipids 1996, 31, 91–97. [CrossRef] [PubMed]
246. Carlson, S.E.; Werkman, S.H.; Tolley, E.A. Effect of long-chain n-3 fatt acid supplementation on visual acuity and growth of preterm infants with and without bronchopulmonary dysplasia. Am. J. Clin. Nutr. 1996, 63, 687–697. [PubMed]
247. Root, A.W. Mechanisms of hormone action: General Principals. In Clinical Pediatric Endocrinology; Hung, W., Ed.; Mosby-Year Book: St. Louis, MO, USA, 1992; pp. 1–12.
248. 2 biosynthesis, tissue IGF-I levels, and bone morphometry in chicks. J. Bone Miner. Res. 1996, 11, 1321–1332. [CrossRef] [PubMed]
249. Colombo, J.; Carlson, S.E.; Cheatham, C.L.; Fitzgerald-Gust Afson, K.M.; Kepler, A.; Doty, T. Long-chain polyunsaturated fatty acid supplementation in infancy reduces heart rate and positively affects distribution of attention. Pediatr. Res. 2011, 70, 406–410. [CrossRef] [PubMed]
250. Colombo, J.; Carlson, S.E.; Cheatham, C.L.; Shaddy, D.J.; Kerling, E.H.; Thodosoff, J.M.; Gustafson, K.M.; Brez, C. Long-term effects of LCPUFA supplementation on childhood cognitive outcomes. Am. J. Clin. Nutr. 2013, 98, 403–412. [CrossRef] [PubMed]
251. Alshweki, A.; Munuzuri, A.P.; Bana, A.M.; de Castro, J.; Andrade, F.; Aldamiz-Echevarria, L.; de Pipaon, M.S.; Fraga, J.M.; Couce, M.L. Effects of different arachidonic acid supplementation on psychomotor development in very preterm infants; a randomized trial. Nutr. J. 2015, 14, 101. [CrossRef] [PubMed]
252. Beyerlein, A.; Hadders-Algra, M.; Kennedy, K.; Fewtrell, M.; Singhal, A.; Rosenfeld, E.; Lucas, A.; Bouwstra, H.; Koletzko, B.; von Kries, R. Infant formula supplementation with long-chain polyunsaturated fatty acids has no effect on Bayley developmental scores at 18 months of age-IPD meta-analysis of 4 large clinical trials. J. Pediatr. Gastroenterol. Nutr. 2010, 50, 79–84. [CrossRef] [PubMed]
253. Innis, S.M.; Auestad, N.; Siegman, J.S. Blood lipid docosahexaenoic and arachidonic acid in term gestation infants fed formula with high docosahexaenoic, low eicosapentaenoic acid fish oil. Lipids 1996, 31, 617–625. [CrossRef] [PubMed]
254. Desci, T.; Keleman, B.; Minda, H.; Burus, I.; Kohn, G. Effect of type of early infant feeding on fatty acid composition of plasma lipid classes in full-term infants during the second 6 months of life. J. Pediatr. Gastroenterol. Nutr. 2000, 30, 547–551.
255. Hoffman, D.R.; Boettcher, J.A.; Diersen-Schade, D.A. Toward optimizing vision and cognition in term infants by dietary docosahexaenoic and arachidonic acid supplementation: A review of randomized clinical trials. Prostaglandins Leukot. Essent. Fat. Acids 2009, 81, 151–158. [CrossRef] [PubMed]
256. Ryan, A.S.; Entin, E.K.; Hoffman, J.P.; Kuratko, C.N.; Nelson, E.B. Role of fatty acids in the neurological development of infants. In Nutrition in Infancy, Volume 2, Nutrition and Health;Watson, R.R., Ed.; Springer Science + Business Media: New York, NY, USA, 2013; pp. 331–346.
257. Drover, J.R.; Hoffman, D.R.; Casteneda, Y.S.; Morale, S.E.; Garfield, S.; Wheaton, D.H.; Birch, E.E. Cognitive function in 18-month-old term infants of the DIAMOND study: A randomized, controlled trial with multiple dietary levels of docosahexaenoic acid. Early Hum. Dev. 2011, 87, 223–230. [CrossRef] [PubMed]
258. Makrides, M.; Gibson, R.A.; McPhee, A.J.; Collins, C.T.; Davis, P.G.; Doyle, L.W.; Simmer, K.; Colditz, P.B.; Morris, S.; Smithers, L.G., et al. Neurodevelopment outcomes of preterm infants fed high-dose docosahexaenoic acid: A randomized controlled trial. JAMA 2009, 301, 175–182. [CrossRef] [PubMed]
259. Makrides, M.; Gibson, R.A.; McPhee, A.J.; Yelland, L.; Quinlivan, J.; Ryan, P. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: A randomized controlled trial. JAMA 2010, 304, 1675–1683. [CrossRef] [PubMed]
260. Lucas, A.; Stafford, M.; Morley, R.; Abbott, R.; Stephenson, T.; MacFadyen, U.; Elias-Jones, A.; Clements, H. Efficacy and safety of long-chain polyunsaturated fatty acid supplementation of infant formula milk: A randomized trial. Lancet 1999, 354, 1948–1954. [CrossRef]
261. Fewtrell, M.S.; Morley, R.; Abbott, R.A.; Singhal, A.; Isaacs, E.B.; Stephenson, T.; MacFadyen, U.; Lucas, A. Double-blind, randomized trial of long-chain polyunsaturated fatty acid supplementation in formula fed to preterm infants. Pediatrics 2002, 110, 73–82. [CrossRef] [PubMed]
262. Henriksen, C.; Haugholt, K.; Lindgren, M.; Aurvåg, A.K.; Rønnestad, A.; Grønn, M.; Solberg, R.; Moen, A.; Nakstad, B.; Berge, R.K., et al. Improved cognitive development among preterm infants attributable to early supplementation of human milk with docosahexaenoic acid and arachidonic acid. Pediatrics 2008, 121, 1137–1145. [CrossRef] [PubMed]
263. Westerberg, A.C.; Schei, R.; Henriksen, C.; Smith, L.; Veierød, M.B.; Drevon, C.A.; Iversen, P.O. Attention among very low birth weight infants following early supplementation with docosahexaenoic acid and arachidonic acid. Acta Pediatr. 2011, 100, 47–52. [CrossRef] [PubMed]
264. Clandinin, M.T.; Van Aerde, J.E.; Merkel, K.L.; Harris, C.L.; Springer, M.A.; Hansen, J.W.; Diersen-Schade, D.A. Growth and development of preterm infants fed infant formulas containing docosahexaenoic acid and arachidonic acid. J. Pediatr. 2005, 146, 461–468. [CrossRef] [PubMed]
265. Birch, E.E.; Garfield, S.; Hoffman, D.R.; Uauy, R.; Birch, D.G. A randomized controlled trial of early dietary supply of long-chain polyunsaturated fatty acids and mental development in term infants. Dev. Med. Child Neurol. 2000, 42, 174–181. [CrossRef] [PubMed]
266. Carlson, S.E.; Montalto, M.B.; Ponder, D.L.; Werkman, S.H.; Korones, S.B. Lower incidence of necrotizing enterocolitis in infants fed a preterm formula with egg phospholipids. Pediatr. Res. 1998, 44, 491–498. [CrossRef] [PubMed]
267. Seki, H.; Sasaki, T.; Ueda, T.; Arita, M. Resolvins as regulators of the immune system. Sci. World J. 2010, 10, 18–31. [CrossRef] [PubMed]
268. Das, U.N. Perinatal supplementation of long-chain polyunsaturated fatty acids, immune response and adult diseases. Med. Sci. Monit. 2004, 10, HY19–HY25. [PubMed]
269. D’Vas, N.; Meldrum, S.J.; Dunstan, J.A.; Lee-Pullen, T.F.; Metcalfe, J.; Holt, B.J.; Serralha, M.; Tulic, M.K.; Mori, T.A.; Prescott, S.L. Fish oil supplementation in early infancy modulates developing infant immune responses. Clin. Exp. Allergy 2012, 42, 1206–1216.
270. Khader, S.A.; Gaffen, S.L.; Kolls, J.K. Th17 cells at the crossroads of innate and adaptive immunity against infectious diseases at the mucosa. Mucosal Immunol. 2009, 2, 403–411. [CrossRef] [PubMed]
271. Muc, M.; Kreiner-Moller, E.; Larsen, J.M.; Birch, S.; Brix, S.; Bisgaard, H.; Lauritzen, L. Maternal fatty acid desaturase genotype correlates with infant immune responses at 6 months. Br. J. Nutr. 2015, 114, 891–898. [CrossRef] [PubMed]
272. Barakat, R.; Abou El-Ela, N.E.; Sharaf, S.; El Sagheer, O.; Selim, S.; Tallima, H.; Bruins, M.J.; Hadley, K.B.; El Ridi, R. Efficacy and safety of arachidonic acid for treatment of school-aged children in Schistosoma mansoni high-endemicity regions. Am. J. Trop. Med. Hyg. 2015, 92, 797–804. [CrossRef] [PubMed]
273. Standl, M.; Lattka, E.; Stach, B.; Koletzko, S.; Bauer, C.P.; von Berg, A.; Berdel, D.; Kramer, U.; Schaaf, B.; Roder, S., et al. FADS1 FADS2 gene cluster, PUFA intake and blood lipids in children: Results from the GINIplus and LISAplus Study Group. PLoS ONE 2012, 7, e37780.
274. Makajima, H.; Hirose, K. Role of IL-23 and Th17 cells in airway inflammation in asthma. Immune Netw. 2010, 10, 1–4. [CrossRef] [PubMed]
275. Dong, C. Regulation and pro-inflammatory function of interleukin-17 family cytokines. Immunol. Rev. 2008, 226, 80–86. [CrossRef] [PubMed]
276. Sapone, A.; Lammers, K.M.; Casolaro, V.; CAmmarota, M.; Giulano, M.T.; De Rosa, M.; Stefanile, R.; Mazzarella, G.; Tolone, C.; Russo, M.I., et al. Divergence of gut permeability and mucosal immune gene expression in two gluten-associated conditions: Celiac disease and gluten sensitivity. BMC Med. 2011, 9, 23. [CrossRef] [PubMed]
277. Pastor, N.; Soler, B.; Mitmesser, S.H.; Ferguson, P.; Lifschitz, C. Infants fed docosahexaenoic acid- and arachidonic acid-supplemented formula have decreased incidence of bronchiolitis/bronchitis the first year of life. Clin. Pediatr. 2006, 45, 850–855. [CrossRef] [PubMed]
278. Lapillone, A.; Pastor, N.; Zhuang, W.; Scalabrin, D.M.F. Infants fed formula with added long chain polyunsaturated fatty acids have reduced incidence of respiratory illnesses and diarrhea during the first year of life. BMC Pediatr. 2014, 14, 168. [CrossRef] [PubMed]
279. Birch, E.E.; Carlson, S.E.; Hoffman, D.R.; Fitzgerald-Gustafson, K.M.; Fu, V.L.; Drover, J.R.; Castañeda, Y.S.; Minns, L.; Wheaton, D.K.; Mundy, D., et al. The DIAMOND (DHA Intake and Measurement of Neural Development) Study: A double-masked, randomized controlled clinical trial of the maturation of infant visual acuity as a function of the dietary level of docosahexaenoic acid. Am. J. Clin. Nutr. 2010, 91, 848–859. [CrossRef] [PubMed]
280. Foiles, A.M.; Kerling, E.H.; Wick, J.A.; Scalabrin, D.M.; Colombo, J.; Carlson, S.E. Formula with long chain polyunsaturated fatty acids reduces incidence of allergy in early childhood. Pediatr. Allergy Immunol. 2015. [CrossRef] [PubMed]
281. Hindenes, J.O.; Nerdal, W.; Guo, W.; Di, L.; Small, D.M.; Holmsen, H. Physical properties of the transmembrane signal molecule, sn-1-stearoyl-2-arachidonylglycerol. Acyl chain segregation and its biochemical implications. J. Biol. Chem. 2000, 275, 6857–6867. [CrossRef] [PubMed]
282. Moodley, T.; Vella, C.; Djahanbakhch, O.; Branford-White, C.J.; Crawford, M.A. Arachidonic and docosahexaenoic acid deficits in preterm neonatal mononuclear cell membranes. Implications for the immune response at birth. Nutr. Health 2009, 20, 167–185. [CrossRef] [PubMed]
283. Van Goor, S.A.; Schaafsma, A.; Erwich, J.J.; Dijck-Brouwer, D.A.; Muskiet, F.A. Mildly abnormal general movement quality in infants is associated with high Mead acid and lower arachidonic acid shows a U-shaped relation with the DHA/AA ratio. Prostaglandins Leukot. Essent. Fat. Acids 2010, 82, 15–20. [CrossRef] [PubMed]
284. Groen, S.E.; de Blecourt, A.C.; Postema, K.; Hadders-Algra, M. General movements in early infancy predict neuromotor development at 9 to 12 years of age. Dev. Med. Child Neurol. 2005, 47, 731–738. [CrossRef] [PubMed]
285. Field, C.J.; Thompson, C.A.; Van Aerde, J.E.; Parrott, A.; Euler, A.; Lien, E.; Clandinin, M.T. Lower proportion of CD45R0+ cells and deficient interleukin-10 production by formula-fed infants, compared with human-fed, is correlated with supplementation of long-chain polyunsaturated fatty acids. J. Pediatr. Gastroenterol. Nutr. 2000, 31, 291–299. [CrossRef] [PubMed]
286. Richardson, A.J.; Calvin, C.M.; Clisby, C.; Schoenheimer, D.R.; Montgomery, P.; Hall, J.A. Fatty acid deficiency signs predict the severity of reading and related difficulties in dyslexic children. Prostaglandins Leukot. Essent. Fat. Acids 2000, 63, 69–74. [CrossRef] [PubMed]
287. Burgess, J.R.; Stevens, L.; Zhang, W.; Peck, L. Long-chain polyunsaturated fatty acids in children with attention-deficit hyperactivity disorder. Am. J. Clin. Nutr. 2000, 71, 327S–330S. [PubMed]
288. Chen, J.R.; Hsu, S.F.; Hsu, C.D.; Hwang, L.H.; Yang, S.C. Dietary patterns and blood fatty acid composition in children with attention-deficit hyperactivity disorder in Taiwan. J. Nutr. Biochem. 2004, 15, 467–472. [CrossRef] [PubMed]
289. Young, G.S.; Maharaj, N.J.; Conquer, J.A. Blood phospholipid fatty acid analysis of adults with and without attention deficit/hyperactivity disorder. Lipids 2004, 39, 117–123. [PubMed]
290. Morse, N.L. A meta-analysis of blood fatty acids in people with learning disorders with particular interest in arachidonic acid. Prostaglandins Leukot. Essent. Fat. Acids 2009, 81, 373–389. [CrossRef] [PubMed]
291. Yamada, J.; Banks, A. Evidence for and characteristics of dyslexia among Japanese children. In Annals of Dyslexia; Schatschneider, C., Compton, D., Eds.; Springer: New York, NY, USA, 1994; pp. 103–119.
292. FAO. Dietary Fats and Oils in Human Nutrition; FAO/WHO: Rome, Italy, 1978.
293. FAO/WHO. Fats and Oils in Human Nutrition; Report of a Joint FAO/WHO Expert Consultation, 19 to 26 October 1993; FAO/WHO: Rome, Italy, 1994.
294. FAO. Fats and Fatty Acids in Human Nutrition; FAO/WHO: Rome, Italy, 2010.
295. Codex Alimentarius Commission. Standards for Infant Formula and Formulas for Special Medical Purposes Intended for Infants; CODEX STAN 72-1981, Last Revised 2007; Codex Alimentarius Commission: Rome, Italy, 2007.
296. Codex Alimentarius Commission. Amendments,2015. Available online: http://www.fao.org/fao-whocodexalimentarius/en (accessed on 26 January 2016).
297. Infant Formula Act. H.R.6940—An Act to Amend the Federal Food, Drug, and Cosmetic Act to Strengthen the Authority under that Act to Assure the Safety and Nutrition of Infant Formulas, and for Other Purposes. Fed. Regist. 1980, 50, 45106–45108.
298. European Commission. Commission Directive 2006/141/EC of 22 December 2006 on Infant Formulae and Follow-on Formulae and Amending Directive 1999/21/EC; L.401/1; Official Journal of the European Union: Brussels, Belgium, 2008.
299. Koletzko, B.; Boey, C.C.; Campoy, C.; Carlson, S.E.; Chang, N.; Guillermo-Tuazon, M.A.; Joshi, S.; Prell, C.; Quak, S.H.; Sjarif, D.R., et al. Current information and Asian perspectives on long-chain polyunsaturated fatty acids in pregnancy, lactation, and infancy: Systematic review and practice recommendations from an early nutrition academy workshop. Ann. Nutr. Metab. 2014, 65, 49–80. [CrossRef] [PubMed]
300. Crawford, M.A.; Wang, Y.; Forsyth, S.; Brenna, J.T. The European Food Safety Authority recommendation for polyunsaturated fatty acid composition of infant formula overrules breast milk, puts infants at risk, and should be revised. Prostaglandins Leukot. Essent. Fat. Acids 2015, 102–103, 1–3. [CrossRef] [PubMed]
301. Leaf, A.A.; Leighfield, M.J.; Costeloe, K.L.; Crawford, M.A. Long chain polyunsaturated fatty acids and fetal growth. Early Hum. Dev. 1992, 30, 183–191. [CrossRef]
302. Forsyth, J.S.; Willatts, P.; Agostoni, C.; Bissenden, J.; Casaer, P.; Boehm, G. Long chain polyunsaturated fatty acid supplementation in infant formula and blood pressure in later childhood: Follow up of a randomized controlled trial. Br. Med. J. 2003, 326, 953. [CrossRef] [PubMed]
303. Makrides, M.; Gibson, R.A.; Udell, T.; Ried, K. Supplementation of infant formula with long-chain polyunsaturated fatty acids does not influence the growth of term infants. Am. J. Clin. Nutr. 2005, 81, 1094–1101. [PubMed]